Sildenafil Tablet, Film Coated
Product Images NDC 50090-5415

11 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 50090-5415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafilchemicalstructure (Sildenafilchemicalstructure)

Sildenafilchemicalstructure (Sildenafilchemicalstructure)
Chemical structure of Sildenafil depicted as a molecular diagram showing its atomic bonds, including nitrogen, oxygen, carbon, and sulfur atoms arranged in a complex ring and side chain configuration.*
FDA Label Image

Sildenafilfig1 (Sildenafilfig1)

Sildenafilfig1 (Sildenafilfig1)
A line graph showing change in systolic blood pressure (SBP) in mmHg over time post-dose in hours. The graph compares two groups: one receiving doxazosin plus placebo and the other doxazosin plus 25 mg sildenafil, illustrating trends in SBP reduction over an 8-hour period after dosing.*
FDA Label Image

Sildenafilfig2 (Sildenafilfig2)

Sildenafilfig2 (Sildenafilfig2)
A line graph showing the change in systolic blood pressure (SBP, mmHg) over time (hours) post-dose. It compares two treatments: Doxazosin with Placebo and Doxazosin with Sildenafil 25 mg, illustrating trends in SBP change from 0 to 8 hours post-dose with data points marked.*
FDA Label Image

Sildenafilfig3 (Sildenafilfig3)

Sildenafilfig3 (Sildenafilfig3)
This line graph illustrates the change in systolic blood pressure (SBP) over time post-dose in hours for two groups: Doxazosin with placebo and Doxazosin with Sildenafil 50 mg. The vertical axis shows the change in SBP in mmHg, and the horizontal axis shows time up to 8 hours. The graph compares blood pressure changes between the two treatments over time.*
FDA Label Image

Sildenafilfig4 (Sildenafilfig4)

Sildenafilfig4 (Sildenafilfig4)
A line graph depicting blood pressure changes (mmHg) over time (hours) after dosing, comparing Doxazosin combined with Sildenafil 100 mg to Doxazosin combined with placebo. The x-axis represents time after dosing up to 8 hours, and the y-axis shows blood pressure change in mmHg ranging from -50 to 40. Two lines with markers show the trends for each treatment group.*
FDA Label Image

Sildenafilfig5 (Sildenafilfig5)

Sildenafilfig5 (Sildenafilfig5)
A line graph displaying plasma concentration (ng/mL) of Sildenafil over time post-dose (hours). The graph shows data for treatment with a commercial tablet, indicating peak plasma concentration at around 1-2 hours and a gradual decline up to 24 hours after dosing.*
FDA Label Image

Sildenafilfog6a (Sildenafilfog6a)

Sildenafilfog6a (Sildenafilfog6a)
A bar chart showing the percentage of patients at endpoint across different categories labeled 0 to 5. Each category contains multiple bars representing subgroups, with one subgroup (represented by black bars) generally increasing in percentage from left to right, reaching about 75% at category 5. The vertical axis measures the percentage of patients, ranging from 0 to 80%.*
FDA Label Image

Sildenafilfog6b (Sildenafilfog6b)

Sildenafilfog6b (Sildenafilfog6b)
Bar chart showing the percentage of patients at endpoint across different categories labeled 0 to 5. The y-axis represents the percentage of patients, ranging from 0 to 80%. Each category on the x-axis displays multiple bars in varying gray shades, representing different groups or variables identified by a legend with values from 0 to 5.*
FDA Label Image

Sildenafilfig7 (Sildenafilfig7)

Sildenafilfig7 (Sildenafilfig7)
A bar graph showing the percentage of patients reporting improvement by treatment group. The groups include Placebo (24%), Sildenafil Tablets 25 mg (63%), 50 mg (74%), and 100 mg (82%). The x-axis shows treatment groups with sample sizes, and the y-axis shows percentage improvement from 0 to 100%.*
FDA Label Image
FDA Label Image

Label Image (Lbl500905415)

Label Image (Lbl500905415)
Sildenafil 50 mg film-coated tablets label from A-S Medication Solutions showing the product name, strength, dosage form, lot number, storage instructions (store at 68 to 77 degrees Fahrenheit), and package size of 10 tablets. The label also includes a QR code and dosing instructions to see the package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.